GrowthAdvisory

An independent review of a major commercial decision, before you commit.

The plan is ready. The commitment is large. Second Opinion puts one independent set of eyes on it before the signature, with nothing to sell you and nothing to gain from the answer.

And a second opinion here does not mean a yes or a no. It means your plan comes back stronger: every weak point found is paired with the measure that fixes it, before the money moves.

Book a Discovery Call Take the Readiness Check

Who it is for

Built for pharma decision makers

Major commercial decision makers in pharma companies, facing a decision that is large, expensive to reverse, and already drafted by their team or advisors.

What kinds of decisions

Any commercial decision where the commitment is large and reversal is costly.

For example: a new division or divisionalization, a field force expansion or restructuring, a new product or launch investment, a brand acquisition, divestment or in-licensing deal, a pricing, scheme or channel restructuring, a large marketing or digital commitment, or a market or geography entry.

If your decision is not on this list but carries that weight, it qualifies. The list is illustrative, not the boundary.

How it works

One independent set of eyes, from proposal to walkthrough

Step 1

You share the proposal your team has prepared, with its workings, under NDA.

Step 2

Most reviews complete in five to seven working days from complete submission. The exact clock is agreed with you on day one. Then we examine the assumptions that carry the plan and verify them against your own numbers.

Step 3

You receive a written review in a personal walkthrough: what is sound and credited to your team, what is thin, the specific measures that strengthen the plan before signature, and the numbers to watch in the first ninety days if you proceed.

Named deliverables

What you receive, and what we never do

You receive

A written Second Opinion Report with a strengthening measure against every thin assumption, a ninety day monitoring plan with named trigger numbers, and a personal walkthrough with the founder.

We never do

Pass or fail verdicts, grades on your team, or predictions dressed as certainty. The review strengthens the plan; the decision, and the credit for it, remain yours.

Second Opinion is part of GrowthAdvisory: an independent, pre signature review of a big commercial decision before you sign, with named deliverables, fixed fees and a written scope.

Common questions

Questions pharma decision makers ask

Will this grade my team or their proposal?

No. The review strengthens the plan. Everything that holds up is credited to your team, in writing.

What if the review finds serious risks?

You hear them plainly, in person, and each one comes with the measure that strengthens it or the number that watches it. The decision remains yours.

My decision is effectively already made. Is a review still useful?

A review of a made decision is not honest work, and we will say so. What helps then is a monitoring plan for the first ninety days of the committed decision. Ask us for that instead.

Not sure your decision is ready?

Check if your decision is ready for a Second Opinion

A short Readiness Check, seven quick questions, helps you see whether your decision is at the stage where an independent, pre signature review adds the most value. Take it on WhatsApp, or answer it here on this page.

Take the Readiness Check on WhatsApp

Opens WhatsApp with your first message ready to send.

Prefer to stay anonymous? Answer the same seven questions here.

Second Opinion

Put one independent set of eyes on it before you sign.

The plan is ready and the commitment is large. Bring it to a discovery call, or start with the Readiness Check.

Book a Discovery Call Take the Readiness Check